Why is percutaneous transcatheter treatment indicated for phlegmasia cerulea dolens?

Updated: Oct 30, 2020
  • Author: Donald Schreiber, MD, CM; Chief Editor: Barry E Brenner, MD, PhD, FACEP  more...
  • Print


Phlegmasia cerulea dolens is an indication for emergency catheter-directed thrombolysis in patients with moderate or low bleeding risks. [10] This recommendation is based on reports of limb salvage, which stand in contrast to the high rates of limb amputation and death seen with standard therapies. [11] Surgical thrombectomy remains an effective option in patients at high risk for hemorrhagic complications, although it often results in incomplete thrombus removal, recurrent DVT, and an increased incidence of systemic complications.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!